These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease. Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350 [TBL] [Abstract][Full Text] [Related]
7. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
8. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. Sun XL; Chen SY; Tao SS; Qiao LC; Chen HJ; Yang BL World J Gastroenterol; 2020 Apr; 26(14):1554-1563. PubMed ID: 32327905 [TBL] [Abstract][Full Text] [Related]
10. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae. Maas L; Gao R; Cusumano V; Spartz E; Chowdhury R; Krishna M; Lazarev M; Melia J; Selaru F; Sharma S; Limketkai B; Parian A Dig Dis Sci; 2023 Oct; 68(10):3994-4000. PubMed ID: 37540392 [TBL] [Abstract][Full Text] [Related]
11. Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease. van Hoeve K; Dreesen E; Hoffman I; Van Assche G; Ferrante M; Gils A; Vermeire S J Crohns Colitis; 2018 Nov; 12(11):1316-1325. PubMed ID: 30239644 [TBL] [Abstract][Full Text] [Related]
12. Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease. Steenholdt C; Bendtzen K; Brynskov J; Thomsen OØ; Munck LK; Christensen LA; Pedersen G; Kjeldsen J; Ainsworth MA J Crohns Colitis; 2015 Mar; 9(3):238-45. PubMed ID: 25576753 [TBL] [Abstract][Full Text] [Related]
13. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease. Beltrán B; Iborra M; Sáez-González E; Marqués-Miñana MR; Moret I; Cerrillo E; Tortosa L; Bastida G; Hinojosa J; Poveda-Andrés JL; Nos P Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385 [TBL] [Abstract][Full Text] [Related]
14. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625 [TBL] [Abstract][Full Text] [Related]
15. Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease. Stein R; Lee D; Leonard MB; Thayu M; Denson LA; Chuang E; Herskovitz R; Kerbowski T; Baldassano RN Inflamm Bowel Dis; 2016 Jun; 22(6):1370-7. PubMed ID: 27057683 [TBL] [Abstract][Full Text] [Related]
16. The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease. Hoekman DR; Brandse JF; de Meij TG; Hummel TZ; Löwenberg M; Benninga MA; D'Haens GR; Kindermann A Scand J Gastroenterol; 2015; 50(9):1110-7. PubMed ID: 25865965 [TBL] [Abstract][Full Text] [Related]
17. Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study. Borren NZ; Paulides E; Frinack JL; Olson RN; Willrich MAV; van der Woude CJ; Ananthakrishnan AN Dig Dis Sci; 2021 Oct; 66(10):3548-3554. PubMed ID: 33037969 [TBL] [Abstract][Full Text] [Related]
18. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Schwartz DA; White CM; Wise PE; Herline AJ Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987 [TBL] [Abstract][Full Text] [Related]
19. Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease. Vermeire S; Dubinsky MC; Rabizadeh S; Panetta JC; Spencer EA; Dreesen E; D'Haens G; Dervieux T; Laharie D Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102374. PubMed ID: 38750934 [TBL] [Abstract][Full Text] [Related]
20. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Yarur AJ; Kanagala V; Stein DJ; Czul F; Quintero MA; Agrawal D; Patel A; Best K; Fox C; Idstein K; Abreu MT Aliment Pharmacol Ther; 2017 Apr; 45(7):933-940. PubMed ID: 28211593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]